Breast-conserving therapy for Stage I-II synchronous bilateral breast carcinoma
Smitha Gollamudi(Memorial Sloan Kettering Cancer Center), James L. Connolly(Beth Israel Deaconess Medical Center), Gloria Peiró(Hospital General Universitario de Alicante Doctor Balmis), Rebecca Gelman(Dana-Farber Cancer Institute), Stuart J. Schnitt(Brigham and Women's Hospital), Lindsey Schneider(Harvard University), Jay R. Harris(Harvard University), Barbara Silver(Harvard University), Abram Recht(Beth Israel Deaconess Medical Center)
Cited by 73
Related Papers
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
Molecular characterization of the tumor microenvironment in breast cancer
|Cancer Cell|2004|1.3k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
Prognostic Factors in Breast Cancer
|Archives of Pathology & Laboratory Medicine|2000|1.1k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k